As of February, 4 GW Pharmaceuticals plc (GWPH) Analysts See $-2.99 EPS

On February, 4 GW Pharmaceuticals plc (NASDAQ:GWPH)’s earnings report is awaited by WallStreet, as reported by Faxor. Analysts forecast 23.05 % diference or $-2.99 from the $-2.43 EPS from 2018. After $-2.76 earnings per share was published last quarter, analysts now see negative EPS growth of 8.33 % for GW Pharmaceuticals plc. GWPH is touching $126.14 during the last trading session, after increased 0.51%.Currently GW Pharmaceuticals plc is downtrending after 1.75% change in last January 14, 2018. GWPH has 323,970 shares volume. The stock underperformed the S&P500 by 1.75%.

GW Pharmaceuticals plc (NASDAQ:GWPH) Ratings Coverage

In total 6 analysts cover GW Pharmaceuticals (NASDAQ:GWPH). “Buy” rating has 5, “Sell” are 0, while 1 are “Hold”. (NASDAQ:GWPH) has 83% bullish analysts. 7 are the (NASDAQ:GWPH)’s ratings reports on Jan 14, 2019 according to StockzIntelligence Inc. The company rating was maintained by Cantor Fitzgerald on Monday, December 3. On Friday, September 7 the company was maintained by Morgan Stanley. On Thursday, October 11 the stock of GW Pharmaceuticals plc (NASDAQ:GWPH) earned “Overweight” rating by Morgan Stanley.

GW Pharmaceuticals plc, a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant.The firm is valued at $4.08 billion. It operates through three divisions: Commercial, Sativex Research and Development, and Pipeline Research and Development.Last it reported negative earnings. The firm markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis.

For more GW Pharmaceuticals plc (NASDAQ:GWPH) news released recently go to: Nasdaq.com, Nasdaq.com, Seekingalpha.com, Benzinga.com or Nasdaq.com. The titles are as follows: “4 Sinfully Good Stocks to Watch in 2019 – Nasdaq” released on January 03, 2019, “European ADRs Move Lower in Thursday Trading – Nasdaq” on December 27, 2018, “A Good Time To Buy GW Pharmaceuticals – Seeking Alpha” with a publish date: January 02, 2019, “Cantor Fitzgerald Bullish On GW Pharmaceuticals (NASDAQ:GWPH), Sees 75% Upside Potential – Benzinga” and the last “Why Marijuana Stock GW Pharmaceuticals Dropped 10.5% in November – Nasdaq” with publication date: December 12, 2018.

GW Pharmaceuticals plc (NASDAQ:GWPH) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.